TLI, TBI, ATG & Hematopoietic Stem Cell Transplantation and Recipient T Regs Therapy in Living Donor Kidney Transplantation
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Everett Meyer, MD
Stanford University
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Stanford University
Palo Alto, California, United States
Colin Lenihan, MDEverett Meyer, MDJohn Scandling, MDKent Jensen, PhDRichard Hoppe, MDRobert Lowsky, MDStephan Busque, MDThomas Pham, MDRecruiting - Nothwestern University
Chicago, Illinois, United States
James Mathew, PhDJayesh Mehta, MDJoseph Leventhal, MDLorenzo Gallon, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Feb 2020
- Primary completion
- 1 Nov 2029
- Completion
- 1 Dec 2029
- Last update posted
- 1 Jul 2026
- Registered enrollment
- 22
- Registry id
- NCT03943238
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.